US equities
|
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
SNDK
$1,704.16
▼-0.92%
AAPL
$332.89
▼-0.24%
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
SNDK
$1,704.16
▼-0.92%
AAPL
$332.89
▼-0.24%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Cybin Inc. Common Shares
(NY:
CYBN
)
8.280
UNCHANGED
Last Price
Updated: 8:00 PM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cybin Inc. Common Shares
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
41
42
Next >
Psychedelic Stock Gainers And Losers From March 16, 2022
↗
March 16, 2022
GAINERS: Mindset Pharma (OTC:
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Participation in Upcoming Maxim Group Virtual Growth Conference
March 16, 2022
Via
Investor Brand Network
Cybin to Participate in the 2022 Maxim Group Virtual Growth Conference on March 28-30, 2022
March 16, 2022
From
Cybin Inc.
Via
Business Wire
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today
↗
March 15, 2022
GAINERS: Mind Medicine (NASDAQ:
Via
Benzinga
Wellbeing Digital, Small Pharma Among Top Psychedelic Movers Of Today
↗
March 14, 2022
GAINERS: Wellbeing Digital (OTC:
Via
Benzinga
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today
↗
March 11, 2022
GAINERS: Allied (OTC:
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 10, 2022
↗
March 10, 2022
GAINERS: Revive Therapeutics (OTC:
Via
Benzinga
Cybin Eyes Potential Of First-Of-Its-Kind Study
↗
March 10, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Cybin (NYSE American: CYBN) (NEO: CYBN...
Via
Benzinga
Cybin (NYSE American: CYBN) (NEO: CYBN) Eyes Potential of First-of-Its-Kind Study
March 10, 2022
Via
Investor Brand Network
Psychedelic Stock Gainers And Losers From March 9, 2022
↗
March 09, 2022
GAINERS: ATAI Life Sciences (NASDAQ:
Via
Benzinga
Benzinga Expands Footprint into the Psychedelic Industry with the Launch of the Benzinga Psychedelic Advisory Council
↗
March 09, 2022
DETROIT, March 4, 2022 /PRNewswire/ -- The Benzinga Psychedelics Advisory Council is a collective of the leading minds and voices in the ...
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Eyes Potential of First-of-Its-Kind Study
March 09, 2022
Via
Investor Brand Network
Psychedelic Stock Gainers And Losers From March 8, 2022
↗
March 08, 2022
GAINERS: TripAdvisor (NASDAQ:
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 7, 2022
↗
March 07, 2022
GAINERS: GH Research (NASDAQ:
Via
Benzinga
NetworkNewsAudio – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Differentiates Itself in Psychedelics Space
March 07, 2022
Via
Investor Brand Network
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), Chopra Foundation Partner in Efforts to Support Progress Toward Psychedelic-Based Therapeutics
March 07, 2022
Via
Investor Brand Network
Psychedelic Stock Gainers And Losers From March 4, 2022
↗
March 04, 2022
GAINERS: Wellbeing Digital (OTC:
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 3, 2022
↗
March 03, 2022
GAINERS: Seelos Therapeutics (NASDAQ:
Via
Benzinga
Cybin Teams With Chopra Foundation To Foster Psychedelics Awareness
↗
March 03, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice....
Via
Benzinga
Cybin (NYSE American: CYBN) (NEO: CYBN) Teams with Chopra Foundation to Foster Psychedelics Awareness
March 03, 2022
Via
Investor Brand Network
Psychedelic Stock Gainers And Losers From March 2, 2022
↗
March 02, 2022
GAINERS: Mindset Pharma (OTC:
Via
Benzinga
Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Teams Up with Chopra Foundation to Foster Psychedelics Therapy Awareness
March 02, 2022
Via
Investor Brand Network
Psychedelic Therapies Offer Hope For Mental Health
↗
March 02, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice....
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) CEO to Participate in Fireside Chat at Oppenheimer Annual Healthcare Conference
March 02, 2022
Via
Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
March 02, 2022
Via
Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
March 02, 2022
Via
Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
March 02, 2022
NetworkNewsWire Editorial Coverage New York, NY – March 2, 2022 – Neural plasticity is instrumental in brain health, and the importance of neuroplasticity can’t be overstated. Indeed, the inability of...
Via
FinancialNewsMedia
Psychedelic Stock Gainers And Losers From March 1, 2022
↗
March 01, 2022
GAINERS: Cybin (AMEX:
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 28, 2022
↗
February 28, 2022
GAINERS: Wellbeing Digital (OTC:
Via
Benzinga
Cybin's Study To Potentially Open New Frontiers In Psychedelics
↗
February 28, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice....
Via
Benzinga
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
41
42
Next >
